AID Life Science Holdings Limited provided preliminary unaudited earnings guidance for the three months ended March 31, 2021. The company Group is expected to record a 40% to 50% decrease in loss for the three months ended 31 March 2021 as compared to the loss for the three months ended 31 March 2020. The decrease in loss was mainly attributable to (i) unrealized fair value losses on financial assets at fair value through profit or loss was recognized for the three months ended 31 March 2020, whereas fair value gains was recognized during the Period; and (ii) the decrease in amortization expenses of intangible assets as most of the intangible assets have been fully amortised during the year ended 31 December 2020.